Lung Cancer Survival Not Improved With Tarceva, Avastin Combo

October 6, 2008

Roche Holding AG and Genentech Inc. have reported that a study has found no improvement in the overall survival of lung cancer patients when they were given a combination of Tarceva and Avastin.................Washington (ChattahBox) – Roche Holding AG and Genentech Inc. have reported that a study has found no improvement in the overall survival of lung cancer patients when they were given a combination of Tarceva and Avastin.

These two drugs have been proven to be effective in fighting cancer cells.

Researchers have found though from a Phase III study that combining these drugs does little to improve lung cancer survival.

Researchers tested patients with non-small cell lung cancer, the most common form of the disease for the trial.

One group took Avastin and Tarceva, while another group of patients took just Tarceva.

There was no difference in lung cancer survival between the two groups.


Comments

One Response to “Lung Cancer Survival Not Improved With Tarceva, Avastin Combo”

  1. Lung Cancer Survival on December 11th, 2008 1:23 am

    A small cell lung cancer diagnosis is very challenging.

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.